Table 2.
Groups | n | Mean | SD | SE | χ 2 | P value of Kruskal–Wallis ANOVA |
---|---|---|---|---|---|---|
RAL baseline | ||||||
1 | 13 | 10.38 | 0.870 | 0.241 | 0.749 | 0.687# |
2 | 13 | 10.46 | 0.519 | 0.144 | ||
3 | 13 | 10.62 | 0.768 | 0.213 | ||
Total | 39 | 10.49 | 0.721 | 0.115 | ||
RAL 3 months | ||||||
1 | 13 | 9.00 | 0.816 | 0.226 | 12.303 | 0.002** |
2 | 13 | 8.69 | 0.480 | 0.133 | ||
3 | 13 | 7.77 | 0.832 | 0.231 | ||
Total | 39 | 8.49 | 0.885 | 0.142 | ||
RAL 6 months | ||||||
1 | 13 | 8.77 | 0.725 | 0.201 | 18.721 | 0.000** |
2 | 13 | 7.92 | 0.760 | 0.211 | ||
3 | 13 | 7.00 | 0.816 | 0.226 | ||
Total | 39 | 7.90 | 1.046 | 0.168 | ||
RAL 9 months | ||||||
1 | 13 | 8.77 | 0.725 | 0.201 | 27.352 | 0.000** |
2 | 13 | 7.69 | 0.630 | 0.175 | ||
3 | 13 | 6.62 | 0.506 | 0.140 | ||
Total | 39 | 7.69 | 1.080 | 0.173 |
Group 1: OFD + placebo; Group 2: OFD + ABG + PRF; Group 3: OFD + ABG + PRF + RSV. OFD: Open flap debridement; ABG: Autogenous bone graft; PRF: Platelet-rich fibrin; RSV: 1.2 mg rosuvastatin gel; n: Number of patients; RAL: Relative attachment level; SD: Standard deviation; SE: Standard error